Rubius Therapeutics, Inc.
Biotechnology company · Foxboro, Massachusetts, United States
Rubius Therapeutics, Inc. is a biotechnology company headquartered in Foxboro, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $101 million sold in a notice filed in 2018.
Rubius Therapeutics at a glance
What does Rubius Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $101.2 million sold (2018).
Frequently asked questions about Rubius Therapeutics
Where is Rubius Therapeutics headquartered?
Rubius Therapeutics, Inc. is headquartered in Foxboro, Massachusetts, United States.
What does Rubius Therapeutics do?
Rubius Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Rubius Therapeutics founded?
The earliest incorporation on record for Rubius Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Suono Bio, Inc.Foxborough, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences